Aerospace and defense company Cadre (NYSE: CDRE) will be reporting results tomorrow after the bell. Here’s what to look for.
Cadre missed analysts’ revenue expectations last quarter, reporting revenues of $155.9 million, up 42.5% year on year. It was a mixed quarter for the company, with a beat of analysts’ EPS estimates but a significant miss of analysts’ revenue estimates.
Is Cadre a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Cadre’s revenue to grow 4.7% year on year, slowing from the 41.3% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cadre has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Cadre’s peers in the aerospace and defense segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Axon delivered year-on-year revenue growth of 38.5%, beating analysts’ expectations by 5.4%, and Byrna reported revenues up 26%, topping estimates by 0.9%. Axon traded up 17.6% following the results while Byrna was also up 20.2%.
Read our full analysis of Axon’s results here and Byrna’s results here.
The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the aerospace and defense stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 9.3% on average over the last month. Cadre is up 3.6% during the same time and is heading into earnings with an average analyst price target of $54 (compared to the current share price of $44.62).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
